Amarantus Bioscience Holdings, Inc. (OTC: AMBS), a biotechnology holding company pursuing proprietary therapeutics and diagnostics through its subsidiaries, today announced that it has completed an exclusive worldwide sublicense agreement for development rights of Cutanogen Corporation’s and MANF Therapeutics, Inc.’s pipelines to Emerald Organic Products (OTC: EMOR, or “Emerald”), a diversified cannabidiol (“CBD”)-focused health sciences company. […]

The Children’s Tumor Foundation (CTF) is a foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis (NF). The Foundation is the largest private funder of NF research and works to create the best forms of treatment for sufferers of NF. Annette Bakker, the Children’s Tumor Foundation’s President and Chief […]